MPNST is characterised by LOF of additional tumour suppressor loci, including p16INK4A (CDKN2A) and TP53; however, these alterations are also seen in atypical neurofibroma, the presumed precursor of MPNST. Here, TP53 is linked to malignant peripheral nerve sheath tumor.